MSH|^~\&|LAB|ARH|||201911081452||ORU^R01|4103211|D|2.3|||AL|NE
PID|1||AB00007431|AB7470|LABTEST^REACT^||19860808|M||||||||||AB000315/18|9875988352
OBR|1|33431^LAB|00025781^2609:C00010R^LAB^260919:C10^33431|500.1500^CP4^Chem 4 - Lytes^^^24326-1||201909261020|201909261019|||||||201909261019||||||||||LAB|I||||
OBR|2|33431^LAB|00025781^2609:C00010R^LAB^260919:C10^33431|522.2490^BHCG^Beta-HCG^^^21198-7||201909261020|201909261019|||||||201909261019||||||||||LAB|F||||
OBX|1|ST|522.2510^BHCG R^Beta-HCG^^21198-7^21198-7|1|< 5^^Y|IU/L|<10|N||A^S|F|||201911081452
NTE|1||Method:Beckman Access/DxI
OBR|3|33431^LAB|00025781^2609:C00010R^LAB^260919:C10^33431|531.3800^DIG^Digoxin Level^^^14698-5||201909261020|201909261019|||||||201909261019||||||||||LAB|F||||
OBX|1|ST|531.3900^DIG R^Digoxin^^14698-5^14698-5|1|1.1^^Y|nmol/L|0.6-2.6|N||A^S|F|||201911081452
NTE|1||Optimal Therap. Range for Heart Failure 0.7 - 1.3 nmol/L
NTE|2||Therap. Range for Atrial Fibrillation not well established.
NTE|3||Method:Beckman Access/DxI